Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 6, 2005, Pages 445-446

  Pekçelen, Yüksel ^a,b   Yavuz, Akif S ^a   Namli, Sule ^a   Gücükoglu, Ahmet ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bleeding disorder; Cataract; Factor VIIa; Factor VIII; Inhibitor; Recombinant; Surgery

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADULT; ANESTHESIA; ARTICLE; CASE REPORT; CATARACT; EYE SURGERY; HEMOPHILIA A; HUMAN; MALE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 24044507933     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000175480.85880.e2     Document Type: Article

References (21)

1. Hay CRM, Baglin TP, Collins PW, Hill FGH, Keeling DM. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Hemophilia Centre Doctors' Organization (UKHCDO). Br J Haematol 2000; 111:78-90.
2. Habermann B, Kochmuth K, Scharrer LH, Kurth HA. Management of hemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VII and recombinant factor VIIa (Novoseven®): a single center experience. Haemophilia 2004; 10: 705-712.
3. Poon MC, D'Oiron R, von Depka M, Khair K, Negrier C, Karafoulidou A, et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombastenia: results of an international survey. J Thromb Haemost 2004; 2:1096-1103.
4. Peters M, Heijbor H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nose-bleeds with recombinant factor VIIa. Thromb Haemost 1998; 80:352.
5. Vidarsson B, Onundarson PT. Recombinant FVIIa for bleeding in refractory thrombocytopenia. Thromb Haemost 2000; 83:635-635.
6. Ejlersen E, Melsen T, Ingerslev J, Andreasen RB, Vilstrup H. Recombinant factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol 2001; 36:1081-1085.
7. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 2003; 34:224-229.
8. Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51:431-439; discussion 438-439.
9. Harold RR, Monroe DM, White GC. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 2004; 104:3858-3864.
10. Roberts HR, Monroe DM, Oliver JA, Chang JY, Hoffman M. Newer concepts of blood coagulation. Hemophilia 1998; 4:331-334.
11. Hoffman M, Monroe DM III. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Semin Hematol 2001; 38:6-9.
12. Nicolaisen EM. Antigenicity of recombinant factor VIIa followed through nine years of clinical experience. Blood Coagul Fibrinolysis 1998; 9(Suppl 1):S119-S123.
13. Lund-Hansen T. NovoSeven: Virus safety. Haemostasis 1996; 26(Suppl 1):96-97.
14. Lusher J. Acute hemarthroses: the benefits of early versus late treatment with rFVIIa. Blood Coagul Fibrinolysis 2000; 11:S45-S49.
15. Ingerslev J. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors. Semin Thromb Hemost 2000; 26:425-432.
16. Biron-Andreani, Dupeyron G, Mainemer M, Schved JF. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery. Blood Coagul Fibrinolysis 2001; 4:215-216.
17. Tourbaf KD, Dunlap BE, Ambrius JL, Rodman DJ, Atwal AJ. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor. J Med 1982; 13:399-410.
18. Apter B, McCarthy V, Shapiro SS, Ballas SK. Successful preoperative apheresis of factor VIII antibody using factor VIII concentrate as a replacement fluid [letter]. J Clin Apheresis 1986; 3:140.
19. Erikkson A, Koranyi G, Seregard S, Philipson B. Risk of suprachoroideal hemorrhage with phacoemulsification. J Cataract Refract Surg 1998; 24:793-800.
20. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomized trial of two doses of rFVIIa (NovoSeven) in hemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80:773-778.
21. Wirbelauer C, Weller A, Haberle H, Pham DT. Cataract surgery under topical anesthesia with oral anticoagulants [in German]. Klin Monatsbl Augenheilkde 2004; 221:749-752.